Latest Research in Antiplatelet Therapy and Cardiovascular Diseases
22 research papers · 2026 median publication year
Top Research Topics in Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research — 4 papers
- Antiplatelet Therapy and Cardiovascular Diseases — 4 papers
- Mechanical Circulatory Support Devices — 2 papers
- Cardiac, Anesthesia and Surgical Outcomes — 2 papers
- Cardiac electrophysiology and arrhythmias — 1 papers
- Coronary Interventions and Diagnostics — 1 papers
- Lipoproteins and Cardiovascular Health — 1 papers
- Cardiovascular Effects of Exercise — 1 papers
- Aortic Disease and Treatment Approaches — 1 papers
- Atrial Fibrillation Management and Outcomes — 1 papers
Highest-Cited Papers
- Cardiometabolic and Inflammatory Predictors of Life‐Threatening Ventricular Arrhythmias in Adults Without Structural Heart Diseases
- Limited Impact of High Bleeding Risk Calculation and Peri-Procedural Discussion on Dual-Antiplatelet Therapy Duration and Clinical Outcomes After Percutaneous Coronary Intervention
- Statin use and 28-day survival in critically ill patients with non-acute myocardial infarction cardiogenic shock
- Strenuous Exercise Elicits Sex-Specific Cardiovascular Maladaptation in a Rodent Model: Atrial Fibrillation and Vascular Risk in Females
- Medical Management of Aortic Emergencies in Critical Care Transport
- Pump-controlled retrograde trial off in veno-arterial extracorporeal membrane oxygenation weaning: a scoping review of physiological rationale, protocol heterogeneity, and clinical application
- CARDIOGENIC SHOCK: CONTEMPORARY MANAGEMENT, RISK STRATIFICATION AND PHENOTYPING
- Sign and symptom-level factors associated with in-hospital mortality in patients with ST-elevation and non-ST-elevation myocardial infarction
- Association of Postoperative Cardiac Troponin Elevation with Clinical Outcomes after Coronary Artery Bypass Grafting: A Systematic Review and Meta-Analysis
- Simple risk stratification of patients with ST-segment elevation myocardial infarction: based on the modified DanGer shock trial-derived criteria assessed at initial emergency room presentation
- Shifts Toward Direct Oral Anticoagulants in Ambulatory Care: Utilization Trends and SARIMA Forecasts
- Prophylactic intra-aortic balloon pump in gastrointestinal cancer surgery: a potential approach to mitigate perioperative ischemic risk in severe coronary artery disease
- Shockable rhythm as an independent prognostic factor in patients with non-ST elevation undergoing percutaneous coronary intervention after out-of-hospital cardiac arrest: a registry-based cohort study
- Young Patients Presenting With Suspected ST-Elevation Myocardial Infarction Undergoing Emergency Coronary Angiography: Clinical Characteristics and 1-Year Outcomes.
- Development and Validation of Risk Models for Outcomes of Isolated Coronary Artery Bypass Grafting ― A Nationwide Analysis in Japan ―
- Navigating Ischemic and Bleeding Risks in High Bleeding Risk Patients Undergoing Coronary Intervention
- Comparative evaluation of anti-inflammatory and antioxidant effects of prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention: A prospective cohort study
- Aspirin Omission at the Time of Primary Percutaneous Coronary Intervention in STEMI
- One vs twelve month aspirin after percutaneous coronary intervention for acute myocardial infarction: individual patient-data analysis of TARGET-FIRST and ULTIMATE-DAPT trials
- Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients